Paraskevi Heldin

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Breast Cancer Cells

Radiofrequency Ablation

Polycystic Ovary Syndrome

Hyaluronic Acid

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Chun-Yu Lin, Kaustuv Basu, Aino Ruusala, Inna Kozlova, Yan-Shuang Li, Spyridon S Skandalis, Carl-Henrik Heldin, Paraskevi Heldin
Hyaluronan-Induced CD44-iASPP Interaction Affects Fibroblast Migration and Survival. Cancers 15 (4) (2023)
Chun-Yu Lin, Kaustuv Basu, Aino Ruusala, Inna Kozlova, Yan-Shuang Li, Spyridon S Skandalis, Carl-Henrik Heldin, Paraskevi Heldin
Hyaluronan-Induced CD44-iASPP Interaction Affects Fibroblast Migration and Survival. Cancers 15 (4) (2023)
Chun-Yu Lin, Kaustuv Basu, Aino Ruusala, Inna Kozlova, Yan-Shuang Li, Spyridon S Skandalis, Carl-Henrik Heldin, Paraskevi Heldin
Hyaluronan-Induced CD44-iASPP Interaction Affects Fibroblast Migration and Survival. Cancers 15 (4) (2023)
Theodoros Karalis, Andrew K Shiau, Timothy C Gahman, Spyros S Skandalis, Carl-Henrik Heldin, Paraskevi Heldin
Identification of a Small Molecule Inhibitor of Hyaluronan Synthesis, DDIT, Targeting Breast Cancer Cells. Cancers 14 (23) (2022)
Constantinos Kolliopoulos, Mohamad Moustafa Ali, Casimiro Castillejo-Lopez, Carl-Henrik Heldin, Paraskevi Heldin
CD44 Depletion in Glioblastoma Cells Suppresses Growth and Stemness and Induces Senescence. Cancers 14 (15) (2022)
Theodoros Karalis, Andrew K Shiau, Timothy C Gahman, Spyros S Skandalis, Carl-Henrik Heldin, Paraskevi Heldin
Identification of a Small Molecule Inhibitor of Hyaluronan Synthesis, DDIT, Targeting Breast Cancer Cells. Cancers 14 (23) (2022)
Theodoros Karalis, Andrew K Shiau, Timothy C Gahman, Spyros S Skandalis, Carl-Henrik Heldin, Paraskevi Heldin
Identification of a Small Molecule Inhibitor of Hyaluronan Synthesis, DDIT, Targeting Breast Cancer Cells. Cancers 14 (23) (2022)
Constantinos Kolliopoulos, Athanasios Chatzopoulos, Spyros S Skandalis, Carl-Henrik Heldin, Paraskevi Heldin
TRAF4/6 Is Needed for CD44 Cleavage and Migration via RAC1 Activation. Cancers 13 (5) (2021)